To investigate the induction of calumenin in lung fibroblasts, IMR-90 or MRC-5 cells were treated with CM from A549 lung cancer cells with or without the TGF-β1 receptor inhibitor A83-01 or the miR-21 inhibitors. The gene discussed is CALU; the disease is lung cancer.